Last reviewed · How we verify
NCT03082040
A Home-based Breathing Training on Menopausal Symptoms
NA trial testing home-based breathing training in Menopause in 57 participants. Completed in 20 December 2017.
20 December 2017
Quick facts
| Lead sponsor | Ministry of Science and Technology, Taiwan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 57 |
| Start date | 26 October 2016 |
| Primary completion | 20 December 2017 |
| Estimated completion | 20 December 2017 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- home-based breathing training
Conditions studied
- Menopause — all drugs for Menopause →
- Menopause Related Conditions — all drugs for Menopause Related Conditions →
Sponsor
Ministry of Science and Technology, Taiwan
Who can join
Adults 45 to 64, female only, with Menopause or Menopause Related Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, triple-blinded and randomized controlled trial examining the effects of a home-based breathing training assisted with biofeedback on menopausal symptoms and autonomic functions among community menopausal women. We also examines whether the changes in autonomic functions would be mediators between slow breathing and menopausal symptoms. This study will include menopausal women, aged from 45 to 64, who experienced menopausal symptoms. Participants will be randomly assigned to either an intervention group (n = 80) or a waiting-list control group (n = 80). The intervention group will undergo the home-based breathing training 20 minutes twice daily and participants in the control condition will participate the same breathing training after a four-week waiting list period. The primary outcome measures are menopausal symptoms measured by symptom diaries of menopausal symptoms and the Greene Climacteric Scale (GCS). Secondary outcome measures are autonomic functions expressed by blood pressure (BP), heart rate (HR) and heart rate variability (HRV). Measurements will be taken at baseline, week 4, and week 8.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03082040
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menopause
Currently open trials in the same condition.
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
- NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
- NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting
Other Ministry of Science and Technology, Taiwan trials
Trials by the same sponsor.
- NCT05474248 — Diaphragmatic Breathing Training on Postpartum Anxiety · NA · unknown
- NCT04608721 — Postpartum Anxiety, Breastfeeding and Infant Health Among Taiwanese Women · unknown
- NCT05972668 — Smartphone App for Asthma Self-care: Assessment of Outcomes (Asthma Progession and Costs) · NA · completed
- NCT03379519 — Protocol of Multi-domain Attention Training · NA · completed
- NCT03346564 — Ritual Training Program in HNC Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03082040 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ministry of Science and Technology, Taiwan
- Last refreshed: 5 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03082040.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing